Baxter said last year that it planned to separate its kidney unit in the second half of 2024, likely as a spinoff or sale. Kidney care accounted for about a third of Baxter’s revenue last year.

Carlyle Group ... operations, Baxter said in March that it has been in talks with selected private equity investors about the possibility of selling the kidney care unit. Baxter plans to spin ...

Baxter International (BAX) has agreed to sell its Kidney Care unit to private equity investment company, Carlyle Group (CG) for $3.8 billion. The company will receive roughly $3.5 billion in cash ...

It follows another recent buy from Carlyle ... Vantive, the kidney care unit of medical-tech company Baxter International Inc. Carlyle and Baxter had entered exclusive talks about a deal in ...

Carlyle Group Inc. is acquiring Advance Auto Parts Inc.’s Worldpac unit for $1.5 billion ... Carlyle agreed to acquire Baxter International Inc.’s kidney care business for $3.8 billion.

Carlyle Group (NASDAQ:CG) Inc. is acquiring Worldpac, a unit of Advance Auto Parts ... a $3.8 billion deal to acquire Baxter International Inc.’s kidney care business. Advance Auto Parts ...

announced that they have signed a definitive agreement under which Carlyle will acquire Baxter’s Kidney Care segment, to be named Vantive, for $3.8 billion (For details refer to spinoffresearch ...

Carlyle Group Inc. is acquiring Advance Auto Parts Inc.’s Worldpac unit for $1.5 billion, striking the first major industrial investment for the firm in more than two years. Worldpac ...

(Bloomberg) -- Baxter International Inc. said it will sell its kidney-care unit to the Carlyle Group private equity firm for $3.8 billion, part of the health care company’s efforts to streamline and ...